KODAK DIVESTITURES OF STERLING, OTHER UNITS "NOT A FIRE SALE"
This article was originally published in The Tan Sheet
Executive Summary
KODAK DIVESTITURES OF STERLING, OTHER UNITS "NOT A FIRE SALE," Chairman and CEO George Fisher told a May 3 press conference in New York announcing Kodak's plans to divest Sterling Winthrop, L&F Products and the company's clinical diagnostics business. "This is not a fire sale; these are good properties and we expect to get a very good price for them," Fisher said, adding that "the non- imaging health businesses will do even better without us because they will be a part of somebody else's core strategy."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning